PropertyValue
?:definition
  • Molecular assay reagents intended to identify gene variants associated with periodic paralysis, a collection of heritable conditions characterized by recurring attacks of severe muscle weakness or paralysis that may be associated with elevated or reduced levels of blood potassium (i.e., hyperkalemia, hypokalemia). Genetic variants at multiple loci have been associated with hereditary periodic paralysis. These reagents are intended to detect various types of genetic changes (e.g., deletions, duplications, insertions, single nucleotide polymorphisms) in multiple periodic paralysis-associated loci simultaneously.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C5208795_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C5208795_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all